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Abstract
Background: The toxicity of dusts from mechanical abrasion of multi-walled carbon nanotube (CNT) epoxy
nanocomposites is unknown. We compared the toxic effects of dusts generated by sanding of epoxy composites
with and without CNT. The used CNT type was included for comparison.
Methods: Mice received a single intratracheal instillation of 18, 54 and 162 μg of CNT or 54, 162 and 486 μg of
the sanding dust from epoxy composite with and without CNT. DNA damage in lung and liver, lung inflammation and
liver histology were evaluated 1, 3 and 28 days after intratracheal instillation. Furthermore, the mRNA expression of
interleukin 6 and heme oxygenase 1 was measured in the lungs and serum amyloid A1 in the liver. Printex 90 carbon
black was included as a reference particle.
Results: Pulmonary exposure to CNT and all dusts obtained by sanding epoxy composite boards resulted in recruitment
of inflammatory cells into lung lumen: On day 1 after instillation these cells were primarily neutrophils but on day 3,
eosinophils contributed significantly to the cell population. There were still increased numbers of neutrophils 28 days
after intratracheal instillation of the highest dose of the epoxy dusts. Both CNT and epoxy dusts induced DNA damage
in lung tissue up to 3 days after intratracheal instillation but not in liver tissue. There was no additive effect of
adding CNT to epoxy resins for any of the pulmonary endpoints. In livers of mice instilled with CNT and epoxy
dust with CNTs inflammatory and necrotic histological changes were observed, however, not in mice instilled
with epoxy dust without CNT.
Conclusions: Pulmonary deposition of epoxy dusts with and without CNT induced inflammation and DNA damage in
lung tissue. There was no additive effect of adding CNT to epoxies for any of the pulmonary endpoints. However,
hepatic inflammatory and necrotic histopathological changes were seen in mice instilled with sanding dust from
CNT-containing epoxy but not in mice instilled with reference epoxy.
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Background
Carbon nanotubes (CNTs) are very promising nanoma-
terials due to their many technically applicable properties.
When CNTs are added to epoxy resins to form epoxy/
CNT nanocomposites, these nanocomposites exhibit im-
proved properties such as increased strength combined
with reduced weight of the product [1, 2]. During the life-
cycle of the nanocomposite (e.g., sanding, abrasion, shred-
ding, incineration) CNTs may be released either as free
particles or as part of a matrix.
Several studies on rodents have shown that pulmonary
exposure to different types of CNTs induces an asbestos-
like toxicological response characterized by persistent in-
flammation, granulomas and fibrosis with low no-effect
levels [3–9]. It has been reported that abrasion particles
from one type of epoxy/CNT composite is not cytotoxic
in vitro [10] but little is known of the toxicity in vivo. The
scientific literature on the toxicity of nanocomposites in
general is very limited: to date, we are aware of five papers
that have reported in vivo assessments of degradation
fragments from other types of nanocomposites such as
paints and lacquer with different nanoadditives [11–14],
and plastic and cement with CNT [15]. In terms of in-
flammation, genotoxicity and histological lesions, none of
these studies report increased toxicity of the sanding dust
or other types of degradation fragments from nanocom-
posites compared to the products without nanomaterials.
Knowledge is currently developing on the process-
specific particle emissions and release of fibrous nano-
materials during the life-cycle processes (e.g., sanding,
weathering, shredding, and incineration) of carbon-
based nanocomposites. Recently, it was shown that sig-
nificant fractions of carbon fibers of μm-size diameters
were clearly separated from matrix during industrial-
scale grinding and sanding of layered silica-carbon epoxy
composite [16]. Conversely, sanding of dispersed epoxy/
CNT nanocomposite, using a smaller hand-held sander
in laboratory setup produced only dust epoxy particles
with protruding CNT [17]. The particle distributions
were also found to be similar during sanding of epoxy/
CNT nanocomposites and epoxy without CNTs. Similar
observations has been made in other studies available
[18–21].
The purpose of the present study was to assess the
toxicity, by inflammatory and DNA damaging effect, of
sanding dusts from epoxy composites with and without
CNT for dose-responses following pulmonary exposure
at different time points in mice. In order to be able to
assess if the toxicological changes induced by dust from
epoxy/CNT nanocomposites were similar to changes in-
duced by the pristine CNT, data on the same CNT
(Nanocyl NC7000) as used in the epoxy/CNT nanocom-
posite were included for comparison. Some of the data on
the pristine CNT have been published previously [6, 22]
and these were included for comparison. For the current
study, we produced epoxy boards based on 1) an epoxy
resin product with and without CNT for which we have
full knowledge of content, and 2) an industrial epoxy resin
Epocyl™ with the same CNT but with unknown mass con-
tent of CNT (<20 wt.%) and other additives. Epocyl™ is de-
signed for industrial components, such as rollers, medical
knifes and windmill blades, and for other applications in
the following markets; automotive, sports, marine and
aerospace [23]. For the toxicological testing, we chose to
generate dust by sanding of the nanocomposites because
this is a realistic life cycle scenario and allowed generation
of a sufficient mass of collected dust for toxicity testing.
Results
Physicochemical characterization of particles and dusts
We tested sanding dusts from three different types of epoxy
composite boards with and without CNT: The Danish
Technological Institute provided two epoxy/CNT nano-
composite boards and one epoxy matrix board for the
study: 1) One epoxy nanocomposite contained 0.2 % w/w
CNT Nanocyl NC7000 (EPOXY-CNT), 2) One corres-
ponding epoxy board contained no CNT (EPOXY-REF)
and was considered a reference for the epoxy nanocom-
posite matrix; and 3) EPOCYL™NC R128-04 (EPOCYL)
containing less than 20 wt.% Nanocyl NC7000 (material
safety data sheet [24]). The pristine multi-walled Nanocyl
NC7000 powder (denoted CNT) was included for com-
parison and carbon black Printex 90 (denoted CB) was
included as reference material. Data regarding CNT
NC7000 were published previously and will therefore
not be described in detail [6].
Characteristics of the epoxyboards
Chemical characterisation by WDXRF was performed on
disks cut out of the original boards. It was confirmed by
SEM that these pieces (EPOXY-CNT and EPOCYL) con-
tained CNT (Additional file 1: Figure S1). SEM images
of polished EPOXY-CNT and EPOCYL reveal torn-off
CNT fibers protruding the surface. The appearance of
the composites was very similar. The clustering of the
CNT indicates that CNT in the epoxy were not totally
dispersed.
The elemental composition of the three epoxy mate-
rials was determined in solid disks (4 cm in diameter,
1 cm high) by wave-length dispersive X-ray fluorescence
analysis (WDXRF). The results are shown in Additional
file 2: Figure S2. For comparison, the results for the
CNT Nanocyl powder, previously published in [25], were
included in the figure. For better visualization, only the
upper 0.3 % of the full axis is displayed. The three materials
are chemically very similar; all are composed of 99.8 % C
and between 0.12 and 0.16 wt.% Cl, plus 0.01 wt.% Si. All
three contain Ni, Fe and Cu in trace amounts (<60 ppm).
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There was only a slight difference of less than 0.1 elemental
weight% between EPOCYL and EPOXY-CNT can be ob-
served. EPOCYL contained 0.07 wt.% Mo and 0.01 wt.%
Mg, but no Mo or Mg was detected in the two other epoxy
materials, or in NANOCYL or CB. Traces of S and P were
detected in EPOCYL. The CNT-containing epoxy mate-
rials, EPOCYL and EPOXY-CNT, contained traces of Na,
Al and Zn. Also CNT contained traces of Na, Al, Zn and
other metal elements. CNT contributed with Fe and Al
(>3 % in CNT) to the elemental composition of the CNT-
containing epoxy.
Characteristics of the test materials used for the
toxicological tests
Table 1 shows a summary of the key physicochemical
characteristics of the test materials used in our study.
The CB and CNT materials have been presented previ-
ously and we refer to these papers for more detailed de-
scriptions [6, 26, 27]. The airborne sanding dusts were
measured using an Electrical Low-Pressure Impactor
(ELPI) and characterized morphologically by Scanning
Electron Microscopy (SEM). The airborne particle ELPI
number size-distributions peaked at approximately 20 nm
and 700 nm. No apparent differences were observed be-
tween these size-modes of dusts generated by sanding
of CNT-containing or CNT-free epoxy nanocomposites
(Fig. 1). As we have reported before, the 20 nm size-
mode is strongly dominated by particles generated by
the electrical engine in the sanding machine [17, 28].
The 700 nm size-mode is also in good agreement with
the size-distributions and size-resolved particle gener-
ation rates of the same plates studied in regular sanding
tests [17].
Scanning Electron Microscopy (SEM) of the test mate-
rials showed that the sanding dusts from epoxy/CNT
nanocomposites were dominated by angular and sub-
angular particles with upper sizes around 10 μm (Figs. 2a
and b). Dusts generated by sanding of the EPOCYL and
EPOXY-CNT had similar general morphology and sizes.
CNT protruding from the surfaces were occasionally
observed in dust sanding particles from EPOXY-CNT
(Fig. 2c), but were abundant in dusts from EPOCYL
(Fig. 2d). The protruding CNTs were clearly longer in
NANOCYL than in EPOXY-CNT samples.
Characterization of particles and dusts in instillation vehicle
Dynamic light scattering
The test materials were dispersed by probe-sonication in
Nanopure-filtered water with 2 % v/v C57BL/6 mice
serum and further diluted by serum-water into the con-
centrations used for instillation. All suspensions used for
intratracheal instillation were analyzed by DLS (Dynamic
Light Scattering). The DLS correlation plots suggested
that the test materials dispersed well in the batch disper-
sions and instillation mediums, but the dispersions were
often unstable as indicated by variable hydrodynamic
sizes as well as trending hydrodynamic zeta-sizes and in-
tensity counts (Table 2). The particle size-distributions of
the sanding dust particles prevented full size-distributions
of the raw dispersions used for instillation by DLS.
Table 1 Overview of samples and average data on key physical chemical characteristics
Sample code NRCWE
ID number
Product form Particle sizea BET specific
surface area
Total pore volume TGA mass loss Main elemental
impurities
ng endotoxin/mg
particlec
CNT NRCWE-026 Powder 11 ± 4 nm
(diameter)
4+/− 0.4 μm
(length)
246 m2/g 0.80 cm3/g 87 % Al, Fe, Cob BD
EPOXY-REF NRCWE-034 Sanding dust ND 4.53 m2/g 0.005 cm3/g 99 % ND 3.43E-05
EPOXY-CNT NRCWE-035 Sanding dust ND 2.45 m2/g 0.003 cm3/g 99 % ND 4.12E-06
EPOCYL NRCWE-036 Sanding dust ND 2.65 m2/g 0.003 cm3/g 99 % ND BD
CB Powder 14 nmd 295−338 m2/ge ND ND N (0.82 %),
H(0.01 %)e
3.33E-03
ND not determined, BD below detection limit
aAverage particle dimensions by SEM; bMain elemental impurities as determined by ICP-MS [6]; cEndotoxin content in particles/dust determined by Limulus Amebocyte
Lysate test; dAccording to manufacturer’s data; e [26] and [27]
Fig. 1 Average airborne dust particle size-distributions of the test
materials measured using ELPI
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However, acceptable size-distributions were observed for
CB and CNT.
SEM images of dust in instillation vehicle
The dispersibility of the test materials in the intratra-
cheal instillation mediums was confirmed by scanning
electron microscopy. The morphologies of the sanding
dust particles were verified in the dispersion mediums
where the protruding CNTs were also observed after
sonication (see example in Fig. 2c).
Endotoxin
The endotoxin content in supernatants from particle
suspensions used for intratracheal instillation was mea-
sured using the Limulus Amebocyte lysate enzyme assay
(LAL) as previously described [12]. The amount of endo-
toxin received by mice given the highest tested dose
Fig. 2 SEM-images of sanding dusts distributed onto two-size adhesive carbon tape. Examples of the particle surface morphology. a Overview
showing the typical morphology and particle sizes of sanding dust from epoxy plates (EPOXY-REF), b Sanding dust from epoxy plates without
CNT (EPOXY-REF), c Protruding CNT were rarely observed from BODOPOX added 0.2 % CNT (EPOXY-CNT), d Protruding CNT were frequently
observed from sanding dust particles from EPOCYL added <20 % CNT (EPOCYL)
Table 2 Zeta-average (Zave) and polydispersivity index (PDI) of the instillation mediums as measured by dynamic light-scattering
Dose 486 μg 162 μg 54 μg 18 μg
Samplec Zave (nm) σ PDI σ Zave (nm) σ PDI σ Zave (nm) σ PDI σ Zave (nm) σ PDI σ
CNT–1 142 ±6a 0.400 ±0.019 119 ±1 0.269 ±0.008 111 ±1 0.295 ±0.024
CNT–2 139 ±4a 0.389 ±0.023 116 ±2 0.369 ±0.016 164 ±6 0.471 ±0.076
CNT–3 140 ±2 0.415 ±0.012
EPOXY-REF–1 d831 ±97b 0.311 ±0.037 d1212 ±118b 0.424 ±0.017 d831 ±97a 0.281 ±0.026
EPOXY-REF–2 d858 ±172b 0.228 ±0.080
EPOXY-CNT–1 d1197 ±81a 0.464 ±0.067 d1035 ±50b 0.480 ±0.026 d958 ±113a 0.465 ±0.045
EPOXY-CNT-2 d1090 ±104b 0.445 ±0.029
EPOCYL–1 d857 ±98b 0.416 ±0.042 d883 ±71b 0.477 ±0.033 d755 ±111b 0.402 ±0.049
EPOCYL–2 d785 ±59b 0.458 ±0.054
CB–1 87.5 ±0.4 0.205 ±0.008
CB–2 90.1 ±0.3 0.182 ±0.008
aThe suspension was slightly unstable with less than 5 % change in derived count rate during measurement
bThe suspension was highly unstable with more than 5 % change in derived count rate during measurement
cThe numbers refer to different determinations of the same sample
dUpper size of particles in the sample exceeded the upper sizing-range of the DLS
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(162 μg for CNT/CB and 486 μg sanding dust) was
below 0.01 EU, a dose equivalent to 0.0005 ng endotoxin
or 0.03 ng endotoxin/kg body weight.
Cell count in broncho-alveolar lavage fluid
Mice received a single intratracheal instillation of 18, 54
and 162 μg of CNT or 54,162 and 486 μg of EPOXY-
REF, EPOXY-CNT and EPOCYL. DNA damage in lung
and liver, lung inflammation and liver histology were
evaluated 1, 3 and 28 days after intratracheal instillation.
Furthermore, the mRNA expression of interleukin 6 (Il6)
and heme oxygenase 1 (Hmox-1) was measured in lung
tissue and Serum amyloid A1 (Saa1) was measured in
liver tissue.
To assess the recruitment of inflammatory cells into
the lung lumen, we determined the total number of BAL
cells and the number of macrophages, neutrophils, eo-
sinophils, lymphocytes, and epithelial cells in the BAL
(Table 3). The neutrophil and the eosinophil influx are
shown in Figs. 3 and 4, respectively. Previously published
data on the CNT used in the epoxy are included for
comparison [6].
Sanding dust from all epoxies resulted in increased
numbers of total BAL cells in mice 1 day after intratra-
cheal instillation of all doses (54, 162 and 486 μg). Sig-
nificantly higher numbers of total BAL cells were also
observed at all doses in mice 3 days after intratracheal
instillation of the two CNT containing epoxies, while
only 162 and 486 μg of the reference epoxy resulted in
increased number of total BAL cells. Only the highest
dose (486 μg) resulted in an increase in the total number
of BAL cells 28 days after instillation of dust from the
three epoxies.
Sanding dust from all epoxies resulted in increased
neutrophil cell numbers in mice 1 day after intratracheal
instillation of all doses (54, 162 and 486 μg). Significantly
higher numbers of neutrophils were also observed at all
doses in mice 3 days after intratracheal instillation of the
two CNT containing epoxies, while only 162 and 486 μg
of the reference epoxy resulted in increased number of
neutrophils. Higher numbers of neutrophils were ob-
served in mice 28 days after instillation of 486 μg of dust
from EPOXY-REF, 162 and 486 μg of EPOXY-CNT and
486 μg of EPOCYL.
In mice instilled with sanding dust from epoxies, sig-
nificantly higher number of macrophages were only seen
3 days after intratracheal instillation of EPOXY-CNT
(486 μg) and EPOCYL (162 μg).
Sanding dust from all epoxies resulted in increased eo-
sinophil counts in mice 1 and 3 days after intratracheal
instillation of all doses (54, 162 and 486 μg). None of the
tested materials resulted in increase in eosinophil counts
28 days after instillation.
One day after instillation, increased numbers of lym-
phocytes were only seen in mice instilled with the high-
est dose of EPOXY-REF and EPOXY-CNT (486 μg).
Sanding dust from all epoxies resulted in increased
lymphocyte counts 3 days after intratracheal instillation
of the two highest doses (162 and 486 μg). In addition,
instillation of 54 μg of dust from the two CNT contain-
ing epoxies resulted in increased number of lympho-
cytes. Only, instillation of EPOCYL resulted in increased
lymphocyte numbers 28 days after instillation (54 and
486 μg).
Increased numbers of epithelial cells were only seen in
mice 1 day after instillation of CNT and 3 days after in-
stillation of 486 μg of two of the epoxy dusts (EPOXY-
REF and EPOCYL).
Instillation of the reference particle (162 μg CB) re-
sulted in a similar response as observed in our previous
study [12, 29–31]: the inflammatory response was neu-
trophil dominated and persisted 28 days post-exposure.
Increased total cell counts were observed at all time-
points.
Thus, pulmonary inflammation was observed for all
tested materials. There were no differences between
mice intratracheally instilled with dust from the CNT
containing epoxy (EPOXY-CNT) and the reference
epoxy (EPOXY-REF) at any time point for any of the
measured cell types, or between the two CNT containing
epoxies (EPOXY-CNT and EPOCYL).
Il-6 and Hmox-1 mRNA expression in the lungs
Sanding dust from all epoxy dusts resulted in increased
Il-6 mRNA expression level in lung tissue 1 day after
intratracheal instillation of the two highest doses (162
and 486 μg) (Table 4). Significantly increased Il-6 mRNA
expression levels were also observed at the highest dose
in mice 3 days after intratracheal instillation of EPOXY-
REF and EPOCYL, while no increase of the dusts were
seen on day 28 after exposure. There was no difference
in Il-6 mRNA expression levels between mice intratra-
cheally instilled with dust from the CNT containing
epoxy (EPOXY-CNT) and the reference epoxy (EPOXY-
REF) at any time point, or between the two CNT con-
taining epoxies (EPOXY-CNT and EPOCYL).
Sanding dust from EPOXY-REF (the highest dose) and
EPOXY-CNT (all doses) resulted in increased Hmox-1
mRNA expression level in mice 1 day after intratracheal
instillation, while no increase of the dusts were seen on
day 3 and 28 after exposure (Table 4). There was no
difference in Il-6 mRNA expression level between mice
intratracheally instilled with dust from the CNT con-
taining epoxy (EPOXY-CNT) and the reference epoxy
(EPOXY-REF) at any time point, or between the two
CNT containing epoxies (EPOXY-CNT and EPOCYL).
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Table 3 BAL fluid counts in mice 1, 3 and 28 days post exposure to 54 μg, 162 μg and 486 μg sanding dust from epoxy and 162 μg CB
Control EPOXY-REF EPOXY-CNT EPOCYL CBa
1 day 0 μg 54 μg 162 μg 486 μg 54 μg 162 μg 486 μg 54 μg 162 μg 486 μg 162 μg
Neutrophils (x103) 9.4 ± 2.5 37.8 ± 5.0** 110.1 ± 20.8*** 189.3 ± 16.2*** 72.7 ± 8.8*** 154.4 ± 20.1*** 182.3 ± 22.2*** 42.0 ± 7.8** 149.7 ± 12.1*** 188.3 ± 15.2*** 143.7 ± 26.1***
Macrophages (x103) 62.8 ± 5.9 93.5 ± 14.7 72.3 ± 16.7 49.3 ± 6.8 62.5 ± 5.1 70.6 ± 13.1 53.4 ± 2.9 85.8 ± 9.5 65.3 ± 11.6 41.4 ± 7.0 18.4 ± 4.5**
Eosinophils (x103) 1.0 ± 0.5 19.4 ± 3.7*** 51.3 ± 8.7*** 28.1 ± 5.0*** 48.4 ± 9.4*** 91.5 ± 13.7*** 17.4 ± 8.5* 17.6 ± 5.3** 58.8 ± 7.9*** 16.0 ± 7.0** 20.2 ± 5.7**
Lymphocytes (x103) 0.8 ± 0.2 2.8 ± 1.0 3.6 ± 1.0 4.6 ± 1.2* 5.2 ± 1.9 6.6 ± 2.7 6.8 ± 1.3* 2.1 ± 0.6 3.7 ± 1.3 3.5 ± 1.2 0.9 ± 0.5
Epithelial (x103) 8.8 ± 1.6 9.0 ± 1.7 10.7 ± 3.5 13.7 ± 4.2 9.7 ± 2.5 10.8 ± 3.1 13.1 ± 2.8 9.7 ± 2.2 10.6 ± 2.7 13.4 ± 1.7 9.8 ± 2.1
Total BAL cells (x103) 82.8 ± 8.3 162.4 ± 21.0** 248.0 ± 38.2*** 285.0 ± 28.4*** 198.5 ± 11.1*** 334.0 ± 29.1*** 273.0 ± 32.7*** 157.2 ± 15.4** 288.0 ± 22.2*** 262.5 ± 19.9*** 193 ± 26.4**
3 days
Neutrophils (x103) 2.6 ± 1.2 5.0 ± 1.3 40.9 ± 7.3*** 94.5 ± 19.7*** 28.0 ± 8.4*** 26.2 ± 4.8*** 113.5 ± 27.3*** 10.5 ± 1.3** 50.6 ± 8.6*** 151.5 ± 17.6*** 120.2 ± 24.4***
Macrophages (x103) 57.8 ± 5.8 81.0 ± 12.5 96.9 ± 10.6 111.2 ± 22.2 78.0 ± 13.2 95.9 ± 16.4 125.1 ± 23.5* 84.8 ± 8.6 146.9 ± 11.8*** 98.6 ± 32.4 65.5 ± 16.3
Eosinophils (x103) 5.3 ± 4.4 36.8 ± 5.8*** 99.6 ± 22.8*** 30.3 ± 12.9* 95.4 ± 14.0*** 139.5 ± 36.1*** 32.8 ± 9.0* 56.5 ± 22.1*** 173.0 ± 47.7*** 41.8 ± 9.5*** 43.8 ± 16.3
Lymphocytes (x103) 1.7 ± 0.6 2.8 ± 0.6 29.6 ± 7.1*** 53.7 ± 24.2*** 10.6 ± 2.9* 34.2 ± 5.7*** 35.5 ± 21.9 9.3 ± 3.5** 25.5 ± 5.4*** 14.0 ± 3.5*** 3.1 ± 1.4
Epithelial (x103) 7.1 ± 1.5 7.0 ± 0.7 9.5 ± 1.7 21.9 ± 2.4** 8.5 ± 2.6 10.3 ± 3.0 14.1 ± 3.4 11.9 ± 2.5 14.4 ± 2.6 24.6 ± 2.8** 12.8 ± 4.5
Total BAL cells (x103) 74.5 ± 8.8 132.5 ± 17.2 276.5 ± 34.3*** 311.5 ± 64.4*** 220.5 ± 33.4*** 306.0 ± 46.1*** 321.0 ± 67.9*** 173.0 ± 30.8*** 410.5 ± 52.0*** 330.5 ± 31.6*** 254.4 ± 28.3***
28 days
Neutrophils (x103) 6.8 ± 4.2 3.4 ± 1.4 8.8 ± 3.2 29.6 ± 5.4** 6.9 ± 1.7 18.2 ± 4.1* 30.2 ± 5.0*** 5.3 ± 2.1 12.0 ± 2.4 53.8 ± 9.8*** 59.3 ± 8.6***
Macrophages (x103) 60.3 ± 5.7 53.1 ± 11.1 74.6 ± 8.4 100.2 ± 18.3 67.9 ± 12.7 93.1 ± 11.2 99.3 ± 11.9 50.9 ± 5.5 75.0 ± 5.9 84.2 ± 10.1 118.2 ± 29.5
Eosinophils (x103) 20.4 ± 10.1 18.5 ± 8.1 3.2 ± 0.7 3.2 ± 0.8 8.8 ± 2.7 6.3 ± 3.4 2.2 ± 1.0 10.0 ± 3.6 2.2 ± 0.9 2.5 ± 0.7 1.7 ± 1.0
Lymphocytes (x103) 4.9 ± 1.6 6.2 ± 2.1 5.7 ± 1.3 7.9 ± 1.6 4.7 ± 1.4 6.3 ± 0.8 10.1 ± 3.1 10.7 ± 4.0 6.4 ± 1.1 8.6 ± 1.3 36.4 ± 12.6
Epithelial (x103) 9.8 ± 1.9 11.8 ± 3.5 7.2 ± 2.6 13.5 ± 2.2 7.8 ± 2.6 7.6 ± 1.8 14.6 ± 2.7 10.1 ± 3.9 11.0 ± 2.1 12.9 ± 2.8 18.0 ± 3.0
Total BAL cells (x103) 102.3 ± 16.3 93.0 ± 19.2 99.5 ± 11.8 154.5 ± 18.1** 96.0 ± 17.0 131.5 ± 15.5 156.5 ± 12.8 87.0 ± 10.4 106.5 ± 7.5 162.0 ± 16.5* 233.5 ± 23.7**
Mean ± SEM
*p < 0.05 compared to controls, **p < 0.01 compared to controls, ***p < 0.001 compared to controls
There were no statistically significant differences between the three sanding dusts at the 0.05 level
aOne mouse in the 162 μg CB group on day 3 post-exposure was considered an outlier because the total number of BAL cells was 10 times higher than the rest of the group. Therefore the BAL results from this mouse
were excluded from the BAL dataset
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Saa1 mRNA expression in the liver
Since we observed the highest pulmonary inflammatory
response 1 day following intratracheal instillation we
also measured Saa1 mRNA expression in livers at the
same time point from mice instilled with 486 μg of
epoxy sanding dusts or 162 μg CB or CNT. Pulmonary
exposure to CNT, EPOXY-REF, EPOXY-CNTand EPOCYL
induced significant increases in the hepatic Saa1 mRNA
expression levels compared to controls, while there were
no effects in mice exposed to CB (Fig. 5). There were no
statistically significant differences in response between the
three epoxy dusts or CNT.
DNA damage
DNA damage was determined as DNA strand breaks
and alkali labile sites in lung and liver tissue (Table 5) by
the Comet assay.
Lung tissue
Pulmonary exposure to EPOXY-REF induced statistically
significantly increased DNA strand break levels in lung
tissue 1 day after intratracheal instillation of the two
highest doses (162 and 486 μg), while there were no
effects 3 and 28 days after instillation. EPOXY-CNT did
not induce any significant increases in DNA strand
break levels. In contrast, dust from EPOCYL induced
significantly increase in DNA strand break levels 1 day
after instillation of 54 and 162 μg, and 3 days after intra-
tracheal instillation of 162 and 486 μg. There were no
statistically significant differences in response between
the three epoxy dusts. Previously published data on the
CNT used in the epoxy showed that CNT induced pul-
monary DNA damage on day 1 (18 and 54 μg) and day 3
(54 and 162 μg) [22].
Liver tissue
Compared to the vehicle controls, none of the test mate-
rials induced significantly changes in DNA strand break
levels in liver tissue. There were no statistically signifi-
cant differences between the three sanding dusts.
Liver histology
Several histological changes were observed in the liver
(Fig. 6, Table 6). For mice exposed to CNT, EPOXY-CNT
and EPOCYL, the observed histological changes com-
pared to controls were of the inflammatory, degenerative
a b
c d
Fig. 3 Neutrophil influx in the lungs. Neutrophil influx in the lungs of mice exposed to 0, 18, 54 or 162 μg of CNT (a) or 0, 54, 162 or 486 μg of
EPOCYL (b), EPOXY-REF (c) or EPOXY-CNT (d). *, **, ***: Statistically significant compared to control mice at 0.5, 0.01 and 0.001 level, respectively.
The CNT data has been published previously [6]
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and necrotic types (Table 6). Histopathological findings in
the liver have been reported previously for the CNT-
exposed mice and these were included for comparison
[22]. There was no difference in the type of lesions ob-
served for mice exposed to CNT, EPOXY-CNT and
EPOCYL and the incidences were comparable between
the three groups. The granulomas in the mice instilled
with the CNT or EPOCYL appeared bigger compared
to granulomas in the livers of mice exposed to EPOXY-
CNT. The degenerative changes in the three groups,
observed one and three days after instillation were lo-
cated in the central and middle zone of hepatic lobules.
On day 28 after instillation, these lesions were mostly
located peripherally regardless of the doses and the type
of the test material with CNT.
The histological changes in the livers from mice ex-
posed to EPOXY-REF were similar to the controls with
regard to the lack of the inflammatory and necrotic
changes. For the other types of lesions recorded for the
groups exposed to either CNT, EPOXY-CNT or EPO-
CYL low incidences were also noted in the EPOXY-REF
group. Mice instilled with CB displayed hepatic changes
of the type that we have reported before [12].
Discussion
In the present study, we investigated the dose–response
relationships of inflammation and DNA damage of respir-
able dust generated and sampled directly during sanding
of epoxy boards with (EPOXY-CNT) and without CNT
(EPOXY-REF) 1, 3 and 28 days after a single intratracheal
instillation in mice. In addition, an industrial epoxy prod-
uct with CNTs was included (EPOCYL). Our results show
that pulmonary deposition of epoxy dust results in inflam-
mation and pulmonary DNA damage up to 28 days and
3 days after exposure, respectively. There was no additive
effect of adding CNTs to the epoxy compared to the refer-
ence epoxy for any of the measured pulmonary toxico-
logical endpoints. In contrast, instillation with dusts from
epoxy boards with CNT (EPOXY-CNT and EPOCYL) was
associated with histological inflammatory and necrotic
changes in the liver. These changes were also observed for
CNT-instilled mice but not for mice instilled with dust
from EPOXY-REF.
Study design and dose considerations
We chose to study composite materials reinforced with
the CNT Nanocyl NC 7000 because this CNT is widely
a b
c d
Fig. 4 Eosinophil influx in the lungs. Eosinophil influx in the lungs of mice exposed to 0, 18, 54 or 162 μg of CNT (a) or 0, 54, 162 or 486 μg of
EPOCYL (b), EPOXY-REF (c) or EPOXY-CNT (d). *, **, ***: Statistically significant compared to control mice at 0.5, 0.01 and 0.001 level, respectively.
The CNT data has been published previously [6]
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Table 4 Pulmonary mRNA expression levels in mice, 1, 3 and 28 days post-exposure to 54 μg, 162 μg and 486 μg sanding dust from epoxy and 162 μg CB
Control EPOXY-REF EPOXY-CNT EPOCYL CB
1 day 0 μg 54 μg 162 μg 486 μg 54 μg 162 μg 486 μg 54 μg 162 μg 486 μg 162 μg
Il-6 0.08 ± 0.02 0.31 ± 0.19 1.19 ± 0.31*** 2.33 ± 0.53*** 1.45 ± 0.87** 2.32 ± 0.97*** 1.91 ± 0.50*** 0.26 ± 0.10* 2.43 ± 0.09*** 1.35 ± 0.35*** 0.21 ± 0.07
Hmox-1 5.26 ± 0.62 5.98 ± 1.5 13.8 ± 3.0 19.2 ± 2.7** 25.6 ± 10.2 28.9 ± 4.9** 17.2 ± 2.6* 6.85 ± 1.7 17.6 ± 3.8 15.6 ± 3.4 6.22 ± 0.89
3 days
Il-6 0.07 ± 0.01 0.11 ± 0.03 0.51 ± 0.11** 0.6 ± 0.18*** 0.11 ± 0.03 0.33 ± 0.15 0.90 ± 0.30 0.14 ± 0.07 0.25 ± 0.07 4.00 ± 1.28*** 0.29 ± 0.11
Hmox-1 3.95 ± 0.72 4.07 ± 0.75 5.28 ± 1.3 6.47 ± 1.7 5.41 ± 1.5 9.11 ± 2.5 14.2 ± 5.7 7.32 ± 2.2 7.74 ± 2.6 28.3 ± 7.7 5.84 ± 1.45
28 days
Il-6 0.24 ± 0.05 0.13 ± 0.03 0.21 ± 0.10 0.25 ± 0.08 0.15 ± 0.08 0.14 ± 0.05 0.17 ± 0.07 0.15 ± 0.03 0.11 ± 0.03 0.33 ± 0.11 0.21 ± 0.05
Hmox-1 4.95 ± 0.72 5.46 ± 1.3 9.33 ± 2.0 7.72 ± 1.3 3.40 ± 0.84 7.00 ± 2.3 7.38 ± 2.5 6.63 ± 1.0 5.70 ± 0.40 12.9 ± 1.04 4.87 ± 1.6
Normalised mRNA expression level of Il-6 and Hmox-1 (Mean ± SEM)
There were no statistically significant differences between the three sanding dusts at the 0.05 level
*p < 0.05 compared to controls, **p < 0.01 compared to controls, ***p < 0.001 compared to controls
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used as reinforcement for many different applications in-
cluding industrial components, such as rollers, medical
knives and windmill blades, and for applications in the
following markets; automotive, sports, marine and aero-
space [2, 23]. The tested materials were chosen to repre-
sent a likely scenario of CNT-reinforced materials. In
addition to EPOXY-REF and EPOXY-CNT for which we
have full knowledge on content, we included a commer-
cially available epoxy CNT composite (EPOCYL). The
EPOXY-CNT contained 0.2 % CNT which was the lar-
gest amount of CNT that could be dispersed in the
matrix. According to the safety datasheet, EPOCYL con-
tained less than 20 % CNT. For this commercially avail-
able CNT-enforced epoxy composite we do not have a
corresponding reference product and we do not have
exact information on the contents.
The chosen doses (pristine nanomaterial:18, 54 and
162 μg, and sanding dust: 54, 162, 486 μg) and time points
(1, 3 and 28 days) are similar to our previous study on
sanding dusts from paints with and without nano tita-
niumdioxide (NanoTiO2) [12]. In that study, the tested
nanopaint contained 10 % NanoTiO2 which made it pos-
sible to compare the toxicity of the NanoTiO2-containing
paint dust to the toxicity of the same amount of both dust
from paint without NanoTiO2 and to the toxicity of the
same dose of pristine NanoTiO2 (eg. 18 μg of pristine
NanoTiO2 corresponds approximately to the amount of
NanoTiO2 in 162 μg of paint). A set-up enabling this com-
parison was not possible in the present study because of
the low CNT content in EPOXY-CNT (0.2 %). Thus the
486 μg dose of EPOXY-CNT should be compared to the
toxicity of less than1 μg of CNT and this dose was ex-
pected to be too low to generate a response. Higher doses
than 486 μg of sanding dust was expected to result in
overload. On the basis of these considerations and for
comparison, we therefore chose to use the same doses of
epoxy dusts as used in the previous study on paint dusts.
We have not been able to identify any studies on ex-
posure levels to sanding dust in epoxy resin workers in
the scientific literature. However, the dust doses (54, 162
and 486 μg) equal pulmonary deposition in mice after 8,
23 and 68 working days of 8 h at the Danish occupa-
tional exposure limit of 5 mg/m3 for respirable inert
mineral dust, respectively (assuming that 10 % of the in-
haled mass is deposited in the pulmonary region, volume
of inhaled air per hour 1.8 l/h and 8 h working days).
For comparison, the doses of CB (18, 54 and 162 μg)
equal pulmonary deposition in mice after 1, 3 and 9
working days of 8 h at the Danish occupational exposure
limit of 3.5 mg/m3 for CB, respectively, (with same as-
sumptions as above except for a higher pulmonary de-
position of CB in the pulmonary region (33 %)) [29].
When considering the recommended occupational ex-
posure limit for CNTs of 1 μg carbon/m3 [5], the lowest
Table 5 DNA damage (%T DNA) in lung and liver tissue, 1, 3 and 28 days post-exposure to 54 μg, 162 μg and 486 μg sanding dust
from epoxy, 162 μg Printex 90 and control mice
Control EPOXY-REF EPOXY-CNT EPOCYL CB
1 day 0 μg 54 μg 162 μg 486 μg 54 μg 162 μg 486 μg 54 μg 162 μg 486 μg 162 μg
Lung 3.25 ± 0.32 3.79 ± 0.30 4.95 ± 0.70* 4.89 ± 0.71* 4.37 ± 0.25 5.80 ± 0.74 4.78 ± 0.42 5.53 ± 0.38* 5.67 ± 0.43* 5.20 ± 0.46 4.60 ± 1.29
Liver 3.13 ± 0.47 3.90 ± 0.48 4.02 ± 0.55 3.30 ± 0.36 3.97 ± 0.71 3.08 ± 0.36 3.32 ± 0.48 3.47 ± 0.34 3.43 ± 0.23 3.07 ± 0.21 3.30 ± 0.24
3 days
Lung 4.28 ± 0.35 4.33 ± 0.36 4.88 ± 0.81 4.45 ± 0.72 5.02 ± 0.74 3.89 ± 0.30 4.30 ± 0.45 4.78 ± 0.54 8.08 ± 1.19** 8.38 ± 2.15* 4.75 ± 0.61
Liver 3.29 ± 0.29 3.3 ± 0.36 3.22 ± 0.44 3.8 ± 0.38 3.25 ± 0.28 2.72 ± 0.24 3.52 ± 0.23 3.07 ± 0.21 3.4 ± 0.23 3.32 ± 0.24 3.62 ± 0.40
28 days
Lung 4.71 ± 0.98 3.13 ± 0.31 4.28 ± 0.49 4.83 ± 0.25 3.70 ± 0.30 3.90 ± 0.45 5.72 ± 0.74 5.28 ± 0.93 4.40 ± 0.65 7.28 ± 1.92 4.67 ± 0.73
Liver 3.78 ± 0.34 3.37 ± 0.35 3.33 ± 0.17 2.78 ± 0.21 2.85 ± 0.27 3.38 ± 0.24 3.17 ± 0.25 3.43 ± 0.41 3.32 ± 0.36 3.63 ± 0.39 3.67 ± 0.55
Mean ± SEM
There were no statistically significant differences in response between the three epoxy dusts
*p < 0.05 compared to controls,**p < 0.01 compared to controls
*** *** *** ***
Fig. 5 Hepatic Saa1 mRNA expression. Normalised Saa1 mRNA
expression levels in the livers of mice exposed to 0 μg (control), 162 μg
nanomaterial (CB or CNT) or 486 μg epoxy dust (EPOXY-REF, EPOXY-CNT
or EPOCYL) 1 day after exposure. ***: Statistically significant compared to
control mice at 0.001 level, respectively. There were no statistically
significant differences between the three sanding dusts at the 0.05 level
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Fig. 6 (See legend on next page.)
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dose of 18 μg/mouse corresponds to the calculated pul-
monary deposition during a 40-year work life exposure
assuming 10 % deposition [3], and a ventilation rate of
1.8 l/h.
Pulmonary toxicity of epoxy composites
Mice intratracheally instilled with epoxy dust responded
with a massive influx of polymorph nuclear cells into the
lung lumen and the same response was observed for
mice instilled with dust from EPOXY-CNT and EPOXY-
REF. Two studies have been published on the pulmonary
toxicity of dusts derived by machining of composite
epoxy materials (graphite fiber-epoxy and fiberglass-
epoxy) [32, 33]. Both reports are based on the same
study of intratracheal instillation of the respirable frac-
tion of six different types of composite epoxy dust
(5 mg/200 g) in rats followed by an evaluation of end-
points 1 month after instillation. The neutrophil influx
was 0.4 to 11.9 % of the BAL cells in the rats instilled
with composite dust [33]. For comparison, in our study
the similar dose (0.486 mg/20 g) resulted in a higher
neutrophil influx (20–30 %) 28 days after exposure. Four
of the six types of dust induced histopathological changes
in the lungs that were more severe than aluminium oxide
(negative control), while none of the dusts resulted in as
severe changes as the ones that were observed in rats ex-
posed to quartz (positive control) [32].
Mice intratracheally instilled with CNT and epoxy dust
responded with a massive influx of eosinophils (previously
discussed in [7]). Eosinophilia after CNT exposure has
also been reported by others [34, 35]. Eosinophils have
primarily been associated with allergic and asthmatic
diseases [36]. Occupational exposure to epoxy resin
hardener has been reported to cause eosinophilic bron-
chitis (reviewed by [37]).
Hepatic effects of pulmonary deposition of epoxy/CNT
composite dust
We observed a number of histological lesions (including
granulomas) in the liver from mice exposed to EPOXY-
CNT and EPOCYL dust compared to dust from EPOXY-
REF. Compared to controls, none of the dusts caused
increased levels of DNA strand breaks in liver tissue.
Several histological liver changes, although of low inci-
dence, were recorded in groups exposed to the dusts from
either epoxy resin without CNT (EPOXY-REF) or from
CNTcontaining epoxy resins (EPOXY-CNTand EPOCYL),
as well as to CNT. The noteworthy finding was that inflam-
matory and necrotic changes were solely recorded in the
CNTgroup and the groups exposed to the CNT-containing
epoxy dusts. This indicates that the pulmonary deposition
of these resins is associated with stronger hepatic effects
compared to the pulmonary deposited epoxy without CNT
(EPOXY-REF).
These hepatic changes could hypothetically be caused
by systemic inflammation, other types of signalling and/
or translocation of CNTs. The two latter possibilities are
considered most likely, since the pulmonary inflamma-
tory response was similar for EPOXY-CNT and EPOXY-
REF and slow translocation of CNTs from the lungs to
the liver and other distant organs has been reported
[38, 39]. This is further supported by 1) the presence of
dark material in macrophages in the livers from the
CNT exposed mice suggesting translocation of CNTs,
and 2) the presence of granulomas in the livers of mice
exposed to EPOXY-CNT and EPOCYL which are similar
to the granulomas detected in the CNT-exposed mice.
We have previously shown that intratracheal instillation
of CNT (including NC7000) induced a strong pulmonary
acute phase response in a dose-dependent manner [22].
The pulmonary acute phase response correlates closely
with neutrophil influx [40]. The strong neutrophil influx
(See figure on previous page.)
Fig. 6 Histopathologic findings in the liver. a: typical microscopic pattern of the mouse liver – the control group. b-h: CNT exposed groups. b:
1 day after instillation (a.i.) to 54 μg: hypertrophy of Kupffer cells (long arrows), numerous binucleate hepatocytes (short arrows); c: 28 days a.i. to
54 μg: − granuloma surrounded by eosinophilic necrotic hepatocytes (long arrow), vacuolar degeneration (short arrows); d: 28 days a.i. to
54 μg: − macrophages (arrows), parenchymatous degeneration; e, f: 1 day after instillation (a.i.) to 162 μg: macrophages (long arrows), vacuolar
degeneration (short arrows); g: 3 days a.i. to 162 μg: pronounced vacuolar degeneration in the central zone of the liver lobule, numerous
binucleate hepatocytes (arrows); h: 28 days a.i. to 162 μg: foci of necrosis (asterisks), small granuloma (head of arrow), hypertrophy of Kupffer cells
(long arrows), oedema (short arrows). i-j: The EPOXY-REF exposed groups, dose 486 μg i – 3 day a.i.: small degree vacuolar degeneration of
hepatocytes; j – 28 days a.i.: typical pattern of the liver. k-n: The EPOXY-CNT exposed groups. k - 3 days a.i. to 162 μg: hyperplasia of Kupffer cells
(arrows); l - 28 days a.i. to 162 μg: vacuolar degeneration on the whole area of the liver lobule, hyperplasia of the bile ducts epithelium (arrows);
m - 28 days a.i. to 162 μg: mild-zonal vacuolar degeneration; n - 3 days a.i.to 486 μg: vacuolar degeneration of hepatocytes on the whole area of
the liver lobule. Staining HE, magnification on the figures a – e and g - m as scale on the figure (n). o-u: The EPOCYL exposed groups. o - 1 day a.i. to
54 μg: hypertrophy of Kupffer cells (arrows); p – 28 days a.i. to 54 μg: vacuolar degeneration on the whole area of the liver lobule, hyperplasia of the
bile ducts epithelium (arrows); r - 1 day a.i. to 162 μg: vacuolar degeneration on the whole area of the liver lobule, hypertrophy of Kupffer cells
(arrows); s – 3 days a.i. to 162 μg: mild-zonal vacuolar degeneration of hepatocytes; t - 3 days a.i. to 486 μg: vacuolar degeneration of hepatocytes
on the whole area of the liver lobule, granuloma surrounded by eosinophilic necrotic hepatocytes (arrow), u: same pattern as on the figure (t) in
double magnification. Staining HE, magnification on the figures (o – s) as scale on the figure (t)
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Table 6 Type and incidence of histological lesions in the liver on days 1, 3 and 28 following exposure of mice to CNT, EPOXY-REF,
EPOXY-CNT, EPOCYL or CB
Lesion Control CNT (μg/animal) EPOXY-REF (μg/animal) EPOXY-CNT (μg/animal) EPOCYL (μg/animal) CB (μg/animal)
0 18 54 162 54 162 486 54 162 486 54 162 486 162
Foci (small) of inflammatory cells
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 1/6 0/6 2/5 0/6 0/6 0/6 0/6 1/6 1/6 0/6 2/6 1/6 0/6
Day 28 0/24 2/6 1/6 1/6 0/6 0/6 0/6 1/6 2/6 2/6 1/6 2/6 2/6 0/6
Granuloma
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 1/6 1/5 0/6 0/6 0/6 0/6 0/6 1/6 0/6 2/6 2/6 0/6
Day 28 0/24 2/6 2/6 1/6 0/6 0/6 0/6 0/6 1/6 1/6 1/6 1/6 2/6 0/6
Polymorphonuclear cell foci
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 1/6 1/5 0/6 0/6 0/6 0/6 0/6 1/6 0/6 1/6 1/6 1/6
Day 28 0/24 2/6 1/6 3/6 0/6 0/6 0/6 1/6 1/6 0/6 1/6 1/6 2/6 2/6
Macrophages
Day 1 0/12 2/6 1/5 1/6 0/6 0/6 0/6 1/6 0/6 0/6 0/6 1/6 0/6 0/6
Day 3 0/22 1/6 2/6 1/5 0/6 0/6 0/6 1/6 2/6 2/6 1/6 2/6 2/6 0/6
Day 28 0/24 1/6 2/6 2/6 0/6 0/6 0/6 0/6 2/6 2/6 1/6 1/6 1/6 0/6
Hyperplasia of connective tissue perivascular
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 0/6 1/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 28 0/24 0/6 0/6 1/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 1/6 0/6
Hyperplasia of connective tissue near bile ductless or venules
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 0/6 1/5 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 1/6
Day 28 0/24 0/6 1/6 1/6 0/6 0/6 0/6 0/6 0/6 1/6 0/6 1/6 2/6 2/6
Microfoci of necrosis
Day 1 0/12 1/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 0/6 1/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 2/6 1/6
Day 28 0/24 1/6 2/6 2/6 0/6 0/6 0/6 0/6 0/6 1/6 0/6 1/6 1/6 1/6
Eosinophilic necrosis of single hepatocytes
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 1/6 1/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 28 0/24 2/6 1/6 2/6 0/6 0/6 0/6 1/6 0/6 1/6 0/6 1/6 1/6 1/6
Hepatocytes with pyknotic nuclei
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 1/6 1/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 1/6
Day 28 0/24 1/6 2/6 2/6 0/6 0/6 0/6 1/6 0/6 1/6 1/6 1/6 2/6 1/6
Parenchymatous degeneration
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 1/6 1/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 1/6
Day 28 0/24 1/6 2/6 2/6 0/6 1/6 0/6 0/6 1/6 1/6 0/6 2/6 2/6 2/6
Vacuolar degeneration
Day 1 0/12 0/6 1/5 2/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 2/6 2/6 0/6
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observed for the epoxy dusts therefore indicate that pul-
monary exposure to all epoxy dusts induces a pulmonary
acute phase response. The pulmonary acute phase re-
sponse following CNT exposure was accompanied by a
hepatic acute phase response 1 and 3 days after exposure
with Saa1 as the most differentially regulated acute phase
gene [22]. In addition, IL-6 is a known inducer of hepatic
acute phase response [41] and was upregulated in mice
exposed to the three epoxy dusts and CNT. We therefore
assessed hepatic Saa1 expression as biomarker of a hep-
atic acute phase response. Our results show that the hep-
atic mRNA expression levels of the acute phase gene Saa1
were increased for all three sanding dusts and the CNT,
while no increased Saa1mRNA expression levels were de-
tected in the CB exposed mice (Fig. 5). During an LPS-
induced hepatic acute phase response, several p450 genes
including Cyp1a2 are down-regulated [41]. In accordance
with this, the mRNA expression levels of a number of
Cyp450 genes including Cyp7a1, Cyp3A44, Cyp1a2 were
found to have lowered expression levels in liver from mice
exposed to the CNT used in this study [22]. Furthermore,
the time-course of lowered Cyp450 expression coincided
with the acute phase response which was strongest on
day 3. The increased hepatic Saa1 expression following
pulmonary exposure to the epoxy dusts thus indicates a
hepatic acute phase response with an accompanying
down-regulation of Cyp450 genes. However, since all
epoxy dusts induced a pulmonary acute phase response,
the acute phase response cannot explain the histo-
logical changes that were only observed in the livers
from mice exposed to CNT-containing epoxy dust.
Physico-chemical characteristics of importance for toxicity
No significant differences in the particle size distribution
between EPOXY-REF and EPOXY-CNT was observed
during sanding [17]. This is in agreement with previous
findings from our study on sanding dusts from paints and
lacquer with and without different additions of nanomater-
ials: a similar size distribution of dusts from similar prod-
ucts without nanomaterials was displayed [28]. A similar
result was also published by Wohlleben and co-workers
who studied the release of nanomaterials during abrasion
of polyoxymethylene/CNT and cement/CNT nanocom-
posites [15]. Therefore, the difference in toxicity that we
observed between the epoxy dusts cannot be explained by
the particle size distributions.
Sanding epoxy boards generated two different size
ranges below and above 100 nm. Similar size distribu-
tions have been observed in previous studies on particle
generation during sanding of different types of materials
Table 6 Type and incidence of histological lesions in the liver on days 1, 3 and 28 following exposure of mice to CNT, EPOXY-REF,
EPOXY-CNT, EPOCYL or CB (Continued)
Day 3 0/22 2/6 2/6 3/5 0/6 0/6 1/6 0/6 1/6 2/6 1/6 2/6 3/6 2/6
Day 28 0/24 1/6 2/6 2/6 0/6 0/6 1/6 0/6 3/6 3/6 0/6 3/6 2/6 2/6
Binucleate hepatocytes
Day 1 1/12 2/6 1/5 1/6 0/6 0/6 0/6 1/6 1/6 0/6 1/6 0/6 1/6 0/6
Day 3 1/22 1/6 2/6 2/5 1/6 2/6 1/6 0/6 1/6 2/6 1/6 2/6 1/6 2/6
Day 28 2/24 2/6 2/6 3/6 1/6 1/6 1/6 2/6 1/6 1/6 2/6 1/6 2/6 2/6
Oedematous endothelial cells of portal venules or close to blood vessels
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 0/6 0/6 1/5 0/6 0/6 0/6 0/6 0/6 1/6 0/6 0/6 0/6 1/6
Day 28 0/24 0/6 2/6 2/6 0/6 0/6 0/6 0/6 1/6 1/6 0/6 1/6 2/6 2/6
Increased number (hyperplasia) of Kupffer cells
Day 1 0/12 0/6 0/5 1/6 1/6 0/6 1/6 0/6 0/6 0/6 0/6 0/6 1/6 0/6
Day 3 0/22 1/6 1/6 2/5 0/6 0/6 0/6 0/6 2/6 2/6 1/6 1/6 1/6 1/6
Day 28 0/24 1/6 2/6 1/6 0/6 0/6 1/6 1/6 1/6 1/6 1/6 1/6 2/6 1/6
Hypertrophy of Kupffer cells
Day 1 0/12 0/6 2/5 2/6 0/6 0/6 0/6 0/6 0/6 1/6 2/6 2/6 2/6 0/6
Day 3 0/22 0/6 3/6 2/5 0/6 1/6 1/6 1/6 2/6 1/6 1/6 2/6 1/6 0/6
Day 28 0/24 1/6 2/6 3/6 0/6 0/6 1/6 0/6 1/6 1/6 0/6 2/6 2/6 1/6
Hyperplasia of bile ducts epithelium
Day 1 0/12 0/6 0/5 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6 0/6
Day 3 0/22 1/6 2/6 1/5 0/6 0/6 0/6 0/6 0/6 0/6 1/6 0/6 1/6 0/6
Day 28 0/24 1/6 1/6 1/6 0/6 0/6 1/6 1/6 1/6 1/6 2/6 2/6 1/6 2/6
Saber et al. Particle and Fibre Toxicology  (2016) 13:37 Page 14 of 20
by sanding machine engines [17, 28, 42]. The study by
Gomez et al. was performed on the same epoxy mate-
rials and with the same sanding machine as in the
present study. Gomez et al. showed that when the sand-
ing machine was running on an empty load the number
size distribution was dominated by particles between 10
and 50 nm [17]. We assume that the emissions by the
sanding machine alone are dominated by Cu-rich parti-
cles [11]. The particles generated by the sanding ma-
chine alone may contribute to the observed toxicological
effects. However, we do not believe that the hepatic
changes in the present study can be explained by the
smallest particles, because no histological changes in the
liver were observed in our previous study of sanding
dust from paints using the same sanding machine [11].
Thus, the sanding dust from paint contained the same
20 nm size-mode fraction, but induced no histological
changes in liver. Therefore, we believe that the hepatic
effects are not caused by the particles emitted by the
sanding machine alone.
Sanding dusts from the epoxy/CNT composites were
characterized by having single CNTs protruding from
the surface of the nanocomposite particles. Protruding
CNTs were also observed in the few other studies char-
acterizing sanding dusts from epoxy/CNT composites
[18–20]. The toxicological significance of sanding dust
particles with these protruding CNTs is unknown. Hypo-
thetically, a release of CNTs from the epoxy-matrix in
the pulmonary region could result in translocation of
CNTs to the systemic circulation and accumulation in
the liver [43, 44]. As described above, the fact that we
see dark material in macrophages in the livers from the
CNT-exposed mice indicates that translocation of CNTs
from the pulmonary region to the liver may have oc-
curred. The presence of CNTs in the liver may contrib-
ute to the difference in hepatic toxicity that we observe.
We do not have information on the specific content
of CNT in the industrial product, EPOCYL (stated to
be <20 %) compared to the experimental CNT epoxy
product. However, based on the very similar amounts
of Fe and Al (the major trace elements in the used
CNT) detected in the two types of CNT epoxy boards
do not indicate that the content of CNT should be very
different. Since we do not know the content of CNT in
EPOCYL and we do not have a control sample without
CNT for this epoxy, we cannot make any conclusions
regarding the cause of the histological changes following
exposure to EPOCYL dust.
It has been shown previously that the inflammatory re-
sponse induced by low-toxicity low-solubility particles
correlates well with the instilled surface area of the particles
[12, 45–47]. In the current study, an association between
deposited surface area and neutrophil influx was seen, but
the association was no better than the corresponding
association between neutrophil influx and instilled mass
(Additional file 3: Figure S3). However, this study does not
have an ideal design for assessing the effect of surface area.
We always include CB as an internal reference particle
in our studies to be able to compare our results across
studies. Moreover, the inclusion of CB in the study
makes it also possible to compare the toxicity of spher-
ical CB with fiber-shaped CNT. These two carbon based
nanomaterials resulted in very different hepatic effects.
Compared to CB, CNT induced much stronger hepatic
Saa1 mRNA expression level and some of the inflamma-
tory lesions recorded for CNT were not observed follow-
ing exposure to CB. Furthermore, our results also show
that all three sanding dusts induced increased hepatic
mRNA expression levels of the acute-phase gene Saa1
while no increased Saa1 mRNA expression levels were
detected in the CB exposed mice. This suggests that the
shape of nanomaterials with similar chemical compos-
ition is of importance for the toxicity. Shape has previ-
ously been shown to be a determinant of pulmonary
response e.g., [48] but we do not know of reports of dif-
ferences in the liver response following pulmonary
exposure.
Summary
Data on the toxicity of epoxy dust are scarce and to the
best of our knowledge, no in vivo studies on the toxicity
of particles generated during mechanical processing of
epoxy/CNT nanocomposites have been published. How-
ever, in addition to the present study on epoxy/CNT
composites, two other studies testing the same CNT
(Nanocyl NC7000) as part of other matrices have been
published by Wohlleben and co-workers: 1) testing of
sanding dust from CNT/cement and CNT/polyoxy-
methylene matrices by pulmonary deposition in rats [15]
and 2) in vitro test of sanding dust from CNT/polyur-
ethane by “Precision Cut Lung Slices” [49]. This means
that CNT Nanocyl NC7000 so far has been tested as
additive in four different matrices and none of the studies
have shown increased pulmonary toxicity of the CNT
matrix compared to the reference matrix without CNT.
However, of these only the present study has assessed
hepatic effects.
Conclusions
The level of pulmonary inflammation and DNA damage
in mice pulmonary exposed to sanding dust from epoxy
boards was not increased by the addition of CNT to the
epoxy matrix. However, sanding dust from CNT-containing
epoxy induced inflammatory and necrotic lesions in the
liver that were not induced by EPOXY-REF but similar to
the histological changes observed following pulmonary ex-
posure to the same CNT.
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Methods
Animals
Female C57BL/6 mice 5–7 weeks old (Taconic, Ry,
Denmark) were acclimatized for 1–3 weeks before the
experiment. Mice were given food (Altromin no. 1324,
Christian Petersen, Denmark) and water ad libitum dur-
ing the whole experiment. The mice were randomly di-
vided into housing groups of 10in polypropylene cages
(425 mm x 266 mm x 150 mm) with pinewood sawdust
bedding and enrichment in form of sticks of aspen wood
and rodent tunnels. The cages were stored at controlled
temperature 21 ± 1 °C and humidity 50 ± 10 % with a 12-h
light:12-h dark cycle.. Female mice were studied at 8 weeks
of age. The average weight at the day of instillation was
18 ± 1.2 g. All animal procedures followed the guidelines
for the care and handling of laboratory animals according
to the EC Directive 86/609/EEC and the Danish law.
The experiments were approved by the Danish “Animal
Experiment Inspectorate” under the Danish Ministry of
Justice (2012-15-2934-00223).
Particles and sanding dusts
Products
The tested pristine nanomaterials comprised of a multi-
walled CNT material (Nanocyl NC7000, CNT), and car-
bon black, Printex 90 (CB), which was included as an
internal reference particle. Printex 90 was a gift from
Degüssa (Germany). In addition, we tested sanding dusts
from three different types of epoxy boards with and
without CNT: The Danish Technological Institute pro-
vided three different types of epoxy boards: 1) an epoxy
product with 0.2 % content of CNT (referred as EPOXY-
CNT), 2) corresponding product without CNT (referred to
as EPOXY-REF) and 3) EPOCYL (Table 1). EPOXY-CNT
and EPOXY-REF were made of the epoxy resin BODOPOX
8000 (Bodotex, Vejle, Denmark) consisting of Bisphenol A
and Bisphenol F. The CNTs were dispersed in the epoxy
resin with 0 wt.% (EPOXY-REF) and 0.2 wt.% (EPOXY-
CNT), respectively. For EPOCYL the used epoxy resin was
an industrial product: EPOCYL™ NC RI 28–04 (Nanocyl
S.A., Belgium). For all three products the curing agent was
INF32 (Bodotex, Vejle, Denmark). The composites were
cured at ca. 23 °C for ca. 24 h, followed by post-curing at
100 °C for minimum 24 h.
Characterization of epoxy boards
The inorganic chemical composition of the epoxy boards
given as elemental weight % was measured by standard-
less wave-length dispersive X-ray fluorescence analysis
(WDXRF) with a Tiger S8 4 kV instrument and Spectra-
Plus Vs.3 software (Bruker, Karlsruhe, Germany). The
three epoxy materials were measured as solid disks (4 cm
in diameter, 1 cm high).
Disks of 4 cm in diameter were cut out of the original
material and polished using a polishing machine LaboPol
(Struers, Ballerup, Denmark). Samples were imaged in a
Helios EBS3 dual-beam SEM (FEI, Eindhoven, The
Netherlands) at 2 kV, 86pA in in-lens mode.
Generation of sanding dusts
Figure 7 shows the experimental set-up used to perform
sanding dust collection. It consists of a sander unit, a
sampling tube, a 0.03 m3 dust reservoir made of plastic,
and a commercial electrostatic precipitator (ESP), previ-
ously characterised by Sharma et al. [50], for particle
sampling. In order to ensure a homogenous sanding of
the surface, the plate material was mounted onto an
electrically rotating disc, 5 rpm, and the sanding ma-
chine was locked in a uniaxial movement along the
surface.
The size distribution of the generated particles was
measured from the chamber using an ELPI+ (Electrical
Low Pressure Impactor, Dekati Ltd., Finland), covering
the range from 6 nm to 10 μm. The total particle con-
centration was measured using a CPC (Condensational
Particle Counter, GRIMM). Sampling for analysis with
electron microscopy was done with TEM-grids mounted
in a 25 mm filter holder with a flow-through of 1 lpm.
Sanding was performed using a commercial hand-held
orbital sander (Metabo Model FSR 200 Intec) with an in-
ternal fan for dust removal. Grit size 120 sanding paper
was used as recommended by the paint and lacquer man-
ufactures. For our purpose the sander outlet was modified
to connect a 60 cm long and 32 mm ID flexible plastic
tube after the sander to lead the dust to the dust reservoir
chamber from which particle measurement and sampling
was done.
The ESP was attached at the side of the chamber
sampling air through a 21 cm deep, 37 cm wide and
15 cm high tunnel made in aluminium (Fig. 7). Sampling
Fig. 7 Experimental set-up. The dust is generated by sanding and
collected by an electrostatic sampler
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to the ELPI, CPC and TEM-grid was performed through
10 mm, TSI Conductive Silicone Tubing, connected to
the end of the chamber.
The sanding procedure was initiated by a 1 min sam-
pling of background air to ensure that a particle free en-
vironment was used. Thereafter the sander was initiated
and ran for 30 s without touching the material surface.
This was done to characterise the particle emissions
from the sanding machine alone. The sanding machine
was placed on the surface. Then the rotation of the plate
and the back-forward motion of the sanding machine
were started. The length of the sanding process varied
from 5 min up to 30 min, depending on the amount of
material created and collected by the ESP. After the ESP
plates were saturated with dust, the sanding machine
was turned off, the collected material were harvested
and placed in glass jars.
Preparation of exposure stock
Particles were suspended by sonication in NanoPure
water containing 2 % v/v serum collected from C57BL/6
mice. The serum was prepared from blood from unex-
posed mice yielding approximately 200 μ1 of serum per
mouse. Serum was prepared by centrifugation of blood
at 400 g (10 min, 4 °C). The particles (3.25 mg/ml) and
dust suspensions (9.75 mg/ml) were sonicated using a
Branson Sonifier S-450D (Branson Ultrasonics Corp.,
Danbury, CT, USA) equipped with a disruptor horn
(Model number: 101-147-037) as described previously
[12]. In brief, the sonication time was 16 min at 400 W
and 10 % amplitude. These suspensions were used for the
high dose (486 μg (dust) and 162 μg (CNT/Printex 90))
and diluted 1:3 for the medium dose and diluted further
1:3 for the low dose. Between the dilutions the suspen-
sions were pipetted. Vehicle control solutions were pre-
pared containing 98 % NanoPure water and 2 % serum.
Particle and dust characterization
Nitrogen sorption isotherms were measured at liquid nitro-
gen temperature (77 K) using a Micromeritics ASAP2020
volumetric adsorption analyzer. Before the measurements,
the samples were degassed under vacuum for 10 h at 80 °C.
The BET (Brunauer- Emmett-Teller) equation [51] was
used to calculate the surface area from adsorption data ob-
tained in the relative pressure (p/po) range of 0.05 and 0.3.
The total pore volume (Vtot) was calculated from the
amount of gas adsorbed at p/po = 0.99. Pore size distribu-
tion curves were derived using Barrett-Joyner-Halenda
(BJH) assuming a cylindrical pore model.
Thermogravimetric analyses were performed on Mettler
TGA instrument by heating the samples from 25 to 900 °C
at a heating rate of 5 °C min-1 on an alumina holder under
the flow of air at 20 ml min-1.
The SEM analyses were performed by using a Zeiss
NVision 40 Cross-Beam Focused Ion Beam machine,
equipped with a high resolution Gemini Field Emission
Gun (FEG) scanning electron microscope column. The
instrument was also equipped with an Oxford INCA 350
Energy Dispersive X-Ray Spectrometer (EDS) incorpor-
ating an X-act silicon drift detector with an energy reso-
lution of 129 eV at the Mn kα line.
A sample of the as-received carbon nanotubes was
prepared by dispersing the powders directly on to a
SEM stub covered with conductive carbon tape. SEM
images were acquired at accelerating voltages of either
3 kV or 8 kV. EDS spectra were obtained from the sam-
ples at an accelerating voltage of 15 keV and a beam
current 0.33 nA.
Samples of the sanding dusts were prepared on carbon
tape on which a TEM grid was also mounted. The con-
ductive tape was intended to facilitate SEM investigations
but the dusts still exhibited highly non-conductive be-
haviour, which required careful adjustment of the work-
ing conditions. Accelerating voltages of 1–10 keV were
used to minimize charging effects.
Characterization of dust and particle suspensions used for
intratracheal instillation
Dynamic light scattering The average sizes of the ma-
terials in instillation vehicle were determined by Malvern
Nano ZS Dynamic Light Scattering (DLS) equipment
mounted with a 633 nm red laser. The optical and die-
lectrical parameters of water were used for the medium
while an optical refraction index of 2.5 and an optical
absorption of 0.3 was used for the sanding dusts. The
optical refraction index for CNT was set to 2.02 and the
absorption was set to 2. Samples were thermally equili-
brated to 25 °C in the DLS equipment before analysis.
Each data point is the average of six consecutive analyses
for each dispersion to measure the hydrodynamic size-
distribution and the evolution of the derived count rate
to assess the stability of the dispersions. The final data
set was calculated considering the measured viscosity of
the dispersion mediums using a SV-10 Vibro Viscometer
(A&D, Japan)
Scanning electron microscopy The dispersion state of
the test materials in the instillation vehicle were char-
acterized by scanning electron microscopy (SEM). Sam-
ples of CNTs in suspension (doses 18 μg and 162 μg)
and dusts (doses 54 μg and 486 μg) used in the instilla-
tion experiments were prepared for SEM by depositing
a small amount of the liquid on SEM-stubs covered
with an Aluminum foil and allowing it to dry before
examination. The SEM procedure was performed as
described above.
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Endotoxin An amount of 3.24 mg/ml of each type of
nanoparticle and 9.72 mg/ml of each type of dust was
suspended in pyrogen free water with 0.05 % Tween 20
and suspended by sonication as described above. The
endotoxin contents were analysed using the kinetic
Limulus Amebocyte Lysate test (Kinetic-QCL endo-
toxin kit, Lonza, Walkersville, MD, USA) as described
previously in [12].
Exposure of mice
The mice were treated with a single intratracheal instil-
lation with 18, 54 and 162 μg for the nanoparticles and
54, 162 and 486 for the epoxy dusts (n = 5–7 per group).
Because the CNT and sanding dust instilled mice were
exposed in two overlapping experiments the number of
control mice differs between the different time points:
day 1 (12 mice), day 2 (22 mice) and on day 3 (24 mice).
Before the intratracheal instillation, the mice were anes-
thetized using isoflurane. The instillation procedure has
been described previously [12]. In brief, a 50 μl particle
or dust suspension was instilled. Control animals were
instilled with vehicle (2 % serum, 98 % NanoPure water).
Preparation of tissue and cells from the mice
One, 3 or 28 days after intratracheal instillation, tissue
and cells were prepared as described previously [12]. In
brief, following anesthesia with Hypnorm®/Dormicum®, a
bronchoalveolar lavage (BAL) was performed by flushing
the lungs twice using (1 ml/25 g body weight) saline in a
1 or 2 ml syringe. Each flush consisted of 3 up and down
movements. The second flush was performed with fresh
saline. The cellular composition of BAL cells was deter-
mined on 200 cells. The total number of cells was deter-
mined by using the NucleoCounter (Chemometec, Allerød,
Denmark) live/dead assay according to the manufacturer’s
instructions. The lungs and a piece of liver tissue were snap
frozen in cryotubes (NUNC) in liquid N2 and stored
at −80 °C. Another piece of liver tissue from the left
lobe was kept in formaldehyde (4 %) until liver histology
was performed.
RNA preparation from lung tissue and Il-6 and Hmox-1
real-time PCR
Total RNA was isolated from lung tissue of 144 mice in
total (n = 6 mice per dose group) using the MagNA Pure
Compact RNA Isolation kit (Roche) according to the
manufacturer’s protocol. In brief, the RNA isolation pro-
cedure is based on the MagNA Pure Magnetic Glass
Particle (MGP) Technology (Roche): nucleic acids are
bound on the surfaces of MGPs whereas unbound mole-
cules are removed by several washing steps. Genomic
DNA molecules are degraded by incubation with DNase.
Total RNA was stored at − 80 °C until analysis.
cDNA synthesis was performed using the Enhanced
Avian HS RT-PCR kit (Sigma-Aldrich), with total RNA
as template, as described in the manufacturer’s protocol.
A total of 500 ng was used for each cDNA synthesis.
The heating cycle was 25 °C (15 min)/50 °C (50 min)/
85 °C (5 min) and the obtained cDNA solutions were
further diluted to a final concentration of 10 ng/μl.
The expression of the target genes, compared to a ref-
erence (GAPDH), was determined with real time-PCR
using a LightCycler® 480 Instrument (Roche) according
to the manufacturer’s protocol. The relative expression
was calculated using the Livak–Schmittgen method [52].
The statistical analyses were performed in Microsoft Excel
through Mathematica (version 8, Wolfram Research).
Statistical significance was calculated using a parametric
one-way ANOVA.
RNA preparation from liver tissue and Saa1 real-time PCR
RNA was prepared from liver tissue using using the
Maxwell 16 LEV simplyRNA tissue kit as as described by
the manufacturer (Promega Biotech AB, Sweden).cDNA
synthesis was performed using the TaqMan® Reverse Tran-
scription Reagents kit (ThermoFisher Scientific, Denmark),
with total RNA as template, as described in the manu-
facturer’s protocol. The expression of hepatic serum
amyloid A 1 (Saa1) and 18S was measured using a
modified TaqMan Fast 2x Universal PCR Master Mix
protocol (ThermoFisher Scientific, Denmark). The pri-
mer/probe mix for Saa1 was Mm00656927_g1 (Ther-
moFisher Scientific, Denmark) and Saa1 mRNA levels
were normalised to 18S. The samples were run in triplicates
on 384-well reaction plates (Thermo Fisher Scientific,
Denmark). A negative (minus reverse transcriptase), a posi-
tive and a blank control were added on each plate. The
plate was run in the ViiA 7 Real-time PCR system (Thermo
Fisher Scientific, Denmark). The relative expression was
calculated using the Livak–Schmittgen method [52].
Comet assay
The level of DNA strand breaks in frozen lung and liver
tissue was determined by the alkaline comet assay using
Imstar as described previously in [53]. As a positive
assay control and to estimate the electrophoresis-to-
electrophoresis variation, 0 and 30 μM H2O2 exposed
A549 cells were included on each Gelbond film in all
electrophoresis runs.
Liver histology
Specimens were taken from the liver of five to six mice
from the vehicle control from the particle and dust dose
groups of all test materials 1, 3 or 28 days after instilla-
tion. The specimens were fixed in 4 % neutral buffered
formaldehyde, paraffin-embedded, and sections 4–6 μm
were made and stained with hematoxylin and eosin for
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histological examination under the Nikon Eclipse 80i
optical microscope equipped with a Nikon PS – Fi1
digital camera (Eclipse 80i; Nikon, Japan) using NIS-
Elements BR 2.30 programme (Nikon, Japan).
Statistics
For each particle, the data were assessed by non-parametric
two-way ANOVA with post-hoc Tukey-type multiple com-
parison test for effects showing statistical significance in the
overall ANOVA test. A comparison of the three dusts was
assessed by non-parametric three-way ANOVA. Statistical
significances were tested at P < 0.05 level. The statistical
analyses were performed in SAS version 9.2 (SAS Institute
Inc., Cary, NC, USA).
Additional files
Additional file 1: Figure S1. SEM images of A) EPOXY-CNT and B) EPOCYL
polished surfaces with CNT (torn-off ends) sticking out. The materials are very
similar in appearance. (PPTX 713 kb)
Additional file 2: Figure S2. Inorganic chemical composition given as
elemental weight% measured by standardless WDXRF. The three epoxy
materials were measured as solid disks (4 cm in diameter, 1 cm high).
For comparison, the results for CNT powder, previously published in [25],
were added to the figure. Displayed axis 99.7 – 100 %. (PPTX 71 kb)
Additional file 3: Figure S3. Correlation between neutrophil influx and
mass (A) or surface area (B) of the instilled particles and sanding dusts.
(PPTX 122 kb)
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